# Cohance Lifesciences Limited – FDA Inspection, Feb 23, 2024

Source: https://www.keypedia.com/records/fda_inspections/cohance-lifesciences-limited/ef957f57-65ad-47f9-a897-5495df26de49
Source feed: FDA_Inspections

> FDA inspection 1234405 of Cohance Lifesciences Limited, February 23, 2024. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1234405
- Company Name: Cohance Lifesciences Limited
- Inspection Date: 2024-02-23
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1335432 - 2026-08-05](https://www.keypedia.com/records/fda_inspections/cohance-lifesciences-limited/00e7a8d5-aa11-4bf5-b5d8-01dec649dd94)
- FDA Inspection 1110488 - 2019-11-01
- [FDA Inspection 1041216 - 2018-02-15](https://www.keypedia.com/records/fda_inspections/cohance-lifesciences-limited/c3fdedea-4c22-4b83-a805-2135836e7f2e)
- FDA Inspection 973825 - 2016-04-14
- FDA Inspection 854615 - 2013-02-08

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/lisa-r-hilliard/611735cf-5c20-424c-801a-03888d8d1b0a)

Company: https://www.keypedia.com/companies/cohance-lifesciences-limited/c01306bf-33dc-4f28-a424-11cda764a0d5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c